Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03980171
Title Study of Lenalidomide, Venetoclax and Obinutuzumab in Patients With Treatment-Naïve Follicular Lymphoma (LEVERAGE)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Peter MacCallum Cancer Centre, Australia

follicular lymphoma


Lenalidomide + Obinutuzumab + Venetoclax

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.